Volume | 2,284 |
|
|||||
News | - | ||||||
Day High | 0.18 | Low High |
|||||
Day Low | 0.1799 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Oncology Institute Inc | TOIIW | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.18 | 0.1799 | 0.18 | 0.175 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
4 | 2,284 | $ 0.1799999 | $ 411 | - | 0.022 - 0.365 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
10:21:16 | 100 | $ 0.18 | USD |
Oncology Institute Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
809.76M | 73.75M | - | 252.48M | 152k | 0.00 | 5,228.57 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Oncology Institute News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TOIIW Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.18 | 0.3133 | 0.175 | 0.1944161 | 3,151 | 0.00 | 0.0% |
1 Month | 0.1659 | 0.365 | 0.1225 | 0.204832 | 2,356 | 0.0141 | 8.5% |
3 Months | 0.08 | 0.365 | 0.06 | 0.1175129 | 6,237 | 0.10 | 125.0% |
6 Months | 0.0521 | 0.365 | 0.022 | 0.0727816 | 13,872 | 0.1279 | 245.49% |
1 Year | 0.125 | 0.365 | 0.022 | 0.0847782 | 11,286 | 0.055 | 44.0% |
3 Years | 1.775 | 1.775 | 0.022 | 0.5593331 | 18,688 | -1.60 | -89.86% |
5 Years | 1.775 | 1.775 | 0.022 | 0.5593331 | 18,688 | -1.60 | -89.86% |
Oncology Institute Description
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financia, counseling, clinical trials, comprehensive lab testing, and end-of-life counseling.The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. |